Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4H8B4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.675 |
CLV_PCSK_FUR_1 | 106 | 110 | PF00082 | 0.672 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.675 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.650 |
CLV_PCSK_PC1ET2_1 | 108 | 110 | PF00082 | 0.654 |
DOC_MAPK_gen_1 | 105 | 113 | PF00069 | 0.487 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.673 |
LIG_14-3-3_CanoR_1 | 106 | 112 | PF00244 | 0.394 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.623 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.521 |
LIG_FHA_1 | 59 | 65 | PF00498 | 0.369 |
LIG_FHA_2 | 27 | 33 | PF00498 | 0.534 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.524 |
LIG_LIR_Nem_3 | 67 | 71 | PF02991 | 0.500 |
LIG_Pex14_2 | 51 | 55 | PF04695 | 0.338 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.651 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.428 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.534 |
LIG_SUMO_SIM_par_1 | 109 | 114 | PF11976 | 0.458 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.514 |
LIG_TRAF2_1 | 96 | 99 | PF00917 | 0.486 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.527 |
MOD_GlcNHglycan | 32 | 36 | PF01048 | 0.475 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.413 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.684 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.386 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.720 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.485 |
MOD_NEK2_2 | 9 | 14 | PF00069 | 0.635 |
MOD_PKA_1 | 107 | 113 | PF00069 | 0.465 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.371 |
MOD_Plk_2-3 | 94 | 100 | PF00069 | 0.513 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.687 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.494 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.652 |
TRG_NLS_MonoCore_2 | 105 | 110 | PF00514 | 0.473 |
TRG_NLS_MonoExtN_4 | 105 | 111 | PF00514 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7L8 | Leptomonas seymouri | 74% | 96% |
A0A0S4JKC2 | Bodo saltans | 45% | 100% |
A0A1X0NUC2 | Trypanosomatidae | 55% | 89% |
A0A3R7MID2 | Trypanosoma rangeli | 57% | 90% |
A0A3S5H6W1 | Leishmania donovani | 86% | 100% |
A4HWN4 | Leishmania infantum | 85% | 100% |
E9AQE2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4QF33 | Leishmania major | 83% | 100% |